SCHEMBL3418188

SCHEMBL3418188

COc1ccccc1N1CCCN(C)CC1

nearest known ligand 0.87

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 5/20 0.87
DRD3 P35462 4/20 0.87
DRD4 P21917 1/20 0.59
HRH2 P25021 1/20 0.59
HRH3 Q9Y5N1 1/20 0.59
HTR6 P50406 2/20 0.58
CYP2C19 P33261 2/20 0.58
HTR3E A5X5Y0 1/20 0.58
HTR3B O95264 1/20 0.58
ADRB1 P08588 1/20 0.58
HTR3A P46098 1/20 0.58
HTR3D Q70Z44 1/20 0.58
HTR3C Q8WXA8 1/20 0.58
SIGMAR1 Q99720 1/20 0.58
USP2 O75604 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
MAPT P10636 3/20 0.57
LMNA P02545 1/20 0.57
NCF1 P14598 1/20 0.56
HTR1A P08908 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL327835 0.93 DRD2 (1.00) DRD2DRD3DRD4HRH2HRH3
Hydrochloric Acid SCHEMBL8576226 0.91 DRD2 (0.96) DRD2DRD3DRD4HRH2HRH3
SCHEMBL30407688 0.89 DRD2 (0.72) DRD2DRD3HTR6CYP2C19HTR3E
SCHEMBL3165674 0.86 DRD2 (0.72) DRD2DRD3DRD4HRH2HTR6
Hydrochloric Acid SCHEMBL26690632 0.84 MAPT (0.71) DRD2DRD3DRD4HRH2HTR6
SCHEMBL3174809 0.84 DRD2 (0.70) DRD2DRD3DRD4HRH2HTR6
SCHEMBL3020451 0.84 DRD2 (0.70) DRD2DRD3DRD4HRH2HTR6
SCHEMBL6187316 0.84 DRD2 (0.81) DRD2DRD3DRD4HRH2HRH3
SCHEMBL3403612 0.83 ALDH1A1 (0.61) DRD2DRD3DRD4SMN1; SMN2MAPT
SCHEMBL3400411 0.83 DRD2 (0.59) DRD2DRD3NCF1HTR1AADRA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3561077-B1 METHODS FOR CELL-PROLIFERATION-RELATED DISORDERS SERVIER LAB (FR) 2022-12-21 EP disclosed
EP-3561077-A1 METHODS AND COMPOSITIONS FOR CELL-PROLIFERATION-RELATED DISORDERS Agios Pharmaceuticals, Inc. (US) 2019-10-30 EP disclosed
EP-2406389-B1 METHODS AND COMPOSITIONS FOR CELL-PROLIFERATION-RELATED DISORDERS AGIOS PHARMACEUTICALS INC (US) 2019-05-08 EP disclosed
WO-2012003418-A2 FUNCTIONALLY SELECTIVE LIGANDS OF DOPAMINE D2 RECEPTORS THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2012-01-05 WO disclosed